{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:34:25Z","timestamp":1772120065204,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12149-025-02141-5","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:54:57Z","timestamp":1765806897000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of serum blood ketone levels and other risk factors for inadequate myocardial glucose suppression ketogenic FDG-PET\/CT: a prospective and retrospective cohort study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6282-7677","authenticated-orcid":false,"given":"Ya Ruth","family":"Huo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Saul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Vinchill","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"12","key":"2141_CR1","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2967\/jnumed.121.261981","volume":"62","author":"C \u00d6z\u00fctemiz","year":"2021","unstructured":"\u00d6z\u00fctemiz C, Koksel Y, Froelich JW, Rubin N, Bhargava M, Roukoz H, Cogswell R, Markowitz J, Perlman DM, Steinberger D. Comparison of the effect of three different dietary modifications on myocardial suppression in 18F-FDG PET\/CT evaluation of patients for suspected cardiac sarcoidosis. J Nucl Med. 2021;62(12):1759\u201367.","journal-title":"J Nucl Med"},{"issue":"3","key":"2141_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s12350-023-03209-3","volume":"30","author":"C Madamanchi","year":"2023","unstructured":"Madamanchi C, Weinberg RL, Murthy VL. Utility of serum ketone levels for assessment of myocardial glucose suppression for 18F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis. J Nucl Cardiol. 2023;30(3):928\u201337.","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"2141_CR3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s12350-023-03199-2","volume":"30","author":"MT Osborne","year":"2023","unstructured":"Osborne MT, Qamar I, Selvaraj S. A level of confidence: beta-hydroxybutyrate and myocardial glucose uptake suppression on 18F-FDG PET imaging. J Nucl Cardiol. 2023;30(3):938\u201340.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"2141_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13550-024-01153-y","volume":"14","author":"S Hartikainen","year":"2024","unstructured":"Hartikainen S, Veps\u00e4l\u00e4inen V, Laitinen T, Hedman M, Laitinen T, Tompuri T. Heparin does not improve myocardial glucose metabolism suppression in [18 F] FDG PET\/CT in patients with low \u03b2-hydroxybutyrate level. EJNMMI Res. 2024;14(1):92.","journal-title":"EJNMMI Res"},{"issue":"5","key":"2141_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12149-024-01910-y","volume":"38","author":"C \u00d6z\u00fctemiz","year":"2024","unstructured":"\u00d6z\u00fctemiz C, Koksel Y, Froelich JW, Rubin N, Bhargava M, Roukoz H, Cogswell R, Markowitz J, Perlman DM, Steinberger D. The active papillary muscle sign in 18F-FDG PET\/CT cardiac sarcoidosis exams and its relationship with myocardial suppression. Ann Nucl Med. 2024;38(5):391\u20139.","journal-title":"Ann Nucl Med"},{"issue":"5","key":"2141_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/cpf.12881","volume":"44","author":"S Hartikainen","year":"2024","unstructured":"Hartikainen S, Tompuri T, Laitinen T, Laitinen T. Point-of\u2010care \u03b2\u2010hydroxybutyrate measurement predicts adequate glucose metabolism suppression in cardiac FDG\u2010PET\/CT. Clin Physiol Funct Imaging. 2024;44(5):349\u201358.","journal-title":"Clin Physiol Funct Imaging"},{"issue":"5","key":"2141_CR7","first-page":"770","volume":"63","author":"S Selvaraj","year":"2022","unstructured":"Selvaraj S, Margulies KB, Dugyala S, Schubert E, Tierney A, Arany Z, Pryma DA, Shah SH, Rame JE, Kelly DP, Bravo PE. Comparison of exogenous ketone administration versus dietary carbohydrate restriction on myocardial glucose suppression: a crossover clinical trial. J Nucl Med. 2022;63(5):770\u20136.","journal-title":"J Nucl Med"},{"issue":"8","key":"2141_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.124.016774","volume":"17","author":"MK Vidula","year":"2024","unstructured":"Vidula MK, Selvaraj S, Rojulpote C, Bhattaru A, Kc W, Hansbury M, et al. Relationship of ketosis with myocardial glucose uptake among patients undergoing FDG PET\/CT for evaluation of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2024;17(8):e016774.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"2141_CR9","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/RLU.0000000000003427","volume":"46","author":"G Abikhzer","year":"2021","unstructured":"Abikhzer G, et al. Impact of dietary noncompliance on myocardial FDG uptake in PET imaging. Clin Nucl Med. 2021;46(2):e75\u201380.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"2141_CR10","first-page":"765","volume":"12","author":"M Osborne","year":"2019","unstructured":"Osborne M et al. T 2019 Ketogenic Preparation for cardiac sarcoidosis imaging: effects on FDG suppression and patient compliance. JACC: Cardiovasc Imaging 12 4 765\u20137.","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"2","key":"2141_CR11","first-page":"199","volume":"58","author":"V Dilsizian","year":"2017","unstructured":"Dilsizian V, Bacharach SL. FDG PET imaging in cardiac sarcoidosis: need for standardization of protocols and interpretation criteria. J Nucl Med. 2017;58(2):199\u2013200.","journal-title":"J Nucl Med"},{"issue":"1","key":"2141_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13550-025-01278-8","volume":"15","author":"S Hartikainen","year":"2025","unstructured":"Hartikainen S, Veps\u00e4l\u00e4inen V, Tompuri T, Laitinen TM, Hedman M, Laitinen T. Cardiometabolic disorders affect myocardial [18F] fluorodeoxyglucose uptake\u2013impact on diagnostic PET\/CT imaging. EJNMMI Res. 2025;15(1):80.","journal-title":"EJNMMI Res"},{"issue":"2","key":"2141_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2362.2008.02068.x","volume":"39","author":"DH van Raalte","year":"2009","unstructured":"van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest. 2009;39(2):81\u201393. https:\/\/doi.org\/10.1111\/j.1365-2362.2008.02068.x.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2141_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0163-7258[02]00297-8","volume":"96","author":"H Schacke","year":"2002","unstructured":"Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96(1):23\u201343. https:\/\/doi.org\/10.1016\/s0163-7258[02]00297-8.","journal-title":"Pharmacol Ther"},{"issue":"12","key":"2141_CR15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2967\/jnumed.121.261997","volume":"62","author":"T Vita","year":"2021","unstructured":"Vita T, Okada DR, Veillet-Chowdhury M, et al. A standardized patient Preparation protocol for FDG PET imaging in cardiac sarcoidosis: the Stepwise use of low-carbohydrate diet, fasting, and heparin. J Nucl Med. 2021;62(12):1759\u201365. https:\/\/doi.org\/10.2967\/jnumed.121.261997.","journal-title":"J Nucl Med"},{"issue":"2","key":"2141_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12350-017-0966-7","volume":"26","author":"MT Osborne","year":"2019","unstructured":"Osborne MT, Hulten EA, Murthy VL, et al. Patient preparation for cardiac fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nuclear Cardiol. 2019;26(2):389\u201399. https:\/\/doi.org\/10.1007\/s12350-017-0966-7.","journal-title":"J Nuclear Cardiol"},{"issue":"14","key":"2141_CR17","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/eurheartj\/ehab864","volume":"43","author":"MR Dweck","year":"2022","unstructured":"Dweck MR, Abgral R, Trivieri MG, et al. The current and future role of cardiac PET imaging. Eur Heart J. 2022;43(14):1206\u201317. https:\/\/doi.org\/10.1093\/eurheartj\/ehab864.","journal-title":"Eur Heart J"},{"key":"2141_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0284185115600916","volume":"57","author":"A Masuda","year":"2016","unstructured":"Masuda A, Naya M, Manabe O, Magota K, Yoshinaga K, Tsutsui H, Tamaki N. Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart. Acta Radiol. 2016;57:661\u20138.","journal-title":"Acta Radiol"},{"issue":"6","key":"2141_CR19","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1007\/s12350-016-0508-1","volume":"24","author":"N Piriou","year":"2017","unstructured":"Piriou N, Vuilleumier H, E Liechti M, et al. The effect of heparin on myocardial glucose uptake: A randomized trial. J Nuclear Cardiol. 2017;24(6):1972\u20137. https:\/\/doi.org\/10.1007\/s12350-016-0508-1.","journal-title":"J Nuclear Cardiol"},{"key":"2141_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","volume":"58","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of [18]F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58:1341\u201353.","journal-title":"J Nucl Med"},{"key":"2141_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13550-024-01153-y","volume":"14","author":"S Hartikainen","year":"2024","unstructured":"Hartikainen S, Veps\u00e4l\u00e4inen V, Laitinen T, Hedman M, Laitinen T, Tompuri T. Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET\/CT in patients with low \u03b2-hydroxybutyrate level. EJNMMI Res. 2024;14:92.","journal-title":"EJNMMI Res"},{"issue":"1","key":"2141_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.17996\/anc.19-00092","volume":"5","author":"S Kumita","year":"2019","unstructured":"Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, et al. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac Sarcoidosis\u20142018 update Japanese society of nuclear cardiology recommendations. Ann Nucl Cardiol. 2019;5(1):141\u201359.","journal-title":"Ann Nucl Cardiol"},{"issue":"2","key":"2141_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00259-022-05964-1","volume":"50","author":"ME Hossain","year":"2023","unstructured":"Hossain ME, Bhandari S, Mueller C. Exogenous ketone esters to achieve myocardial suppression in FDG PET imaging. Eur J Nucl Med Mol Imaging. 2023;50(2):413\u201321. https:\/\/doi.org\/10.1007\/s00259-022-05964-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2141_CR24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/ehjci\/jeac016","volume":"23","author":"B de Vos","year":"2022","unstructured":"de Vos B, Slart RHJA, Glaudemans AWJM. Dietary and Pharmacological approaches to optimize FDG-PET myocardial suppression: an emerging role for ketone supplements? Eur Heart J \u2013 Cardiovasc Imaging. 2022;23(6):810\u20138. https:\/\/doi.org\/10.1093\/ehjci\/jeac016.","journal-title":"Eur Heart J \u2013 Cardiovasc Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02141-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:05:27Z","timestamp":1768165527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02141-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02141-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7776884\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}